BreezeBio

South San Francisco, United States

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

$60.0M raised

Feb 2026

Series B

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about BreezeBio

How much funding has BreezeBio raised?

BreezeBio has raised $60.0M in total funding. The most recent round was Series B. The last funding was announced in February 2026.

Where is BreezeBio headquartered?

BreezeBio is headquartered in South San Francisco, United States.

What does BreezeBio do?

BreezeBio is a biotechnology business that creates genetic therapies using precision, non-viral delivery across clinically important tissues

What stage is BreezeBio at?

BreezeBio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 25, 2026.

MLA

"BreezeBio — Funding & Investors." VCBacked, February 25, 2026, https://www.vcbacked.co/company/breezebio. Accessed June 3, 2026.

APA

VCBacked. (2026). BreezeBio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/breezebio

Wikipedia (cite web)

{{cite web |title=BreezeBio — Funding & Investors |url=https://www.vcbacked.co/company/breezebio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 25, 2026.